Overall, our data show that for tumors derived from gal-9-KO clones, the deployment of the immune response leading to tumor growth arrest requires 2 simultaneous conditions: (1) absence of gal-9 produced by tumor cells; (2) serial transplantation for 2 or 3 cycles of tumor growth. The gene discussed is LGALS9; the disease is neoplasm.